Search

everythinglearnresearchcommunity

for

Search:↓

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Electro-acupuncture may help treat PCOS in rats by changing brain DNA methylation.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Flightless I protein affects hair growth, with low levels delaying it and high levels increasing hair length in rodents.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Oral contraceptives may cause hair loss in women.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Timing of light therapy affects horse coat growth, with photoperiod being crucial.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Young women with PCOS without additional risk factors may have normal heart function.